BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kumar M, Liu ZR, Thapa L, Chang Q, Wang DY, Qin RY. Antiangiogenic effect of somatostatin receptor subtype 2 on pancreatic cancer cell line: Inhibition of vascular endothelial growth factor and matrix metalloproteinase-2 expression in vitroWorld J Gastroenterol 2004; 10(3): 393-399 [PMID: 14760765 DOI: 10.3748/wjg.v10.i3.393]
URL: https://www.wjgnet.com/1007-9327/full/v10/i3/393.htm
Number Citing Articles
1
Si-Xue Liu, Zhong-Sheng Xia, Ying-Qiang Zhong. Gene therapy in pancreatic cancerWorld Journal of Gastroenterology 2014; 20(37): 13343-13368 doi: 10.3748/wjg.v20.i37.13343
2
G. Bocci, M. D. Culler, A. Fioravanti, P. Orlandi, A. Fasciani, R. Colucci, J. E. Taylor, D. Sadat, R. Danesi, M. Del Tacca. In vitro antiangiogenic activity of selective somatostatin subtype‐1 receptor agonistsEuropean Journal of Clinical Investigation 2007; 37(9): 700 doi: 10.1111/j.1365-2362.2007.01848.x
3
Yulin Song, Qixin Zheng, Yongchao Wu, Xiaodong Guo. Two-dimensional effects of hydrogel self-organized from IKVAV-containing peptides on growth and differentiation of NSCsJournal of Wuhan University of Technology-Mater. Sci. Ed. 2009; 24(2): 186 doi: 10.1007/s11595-009-2186-1
4
Hui-Feng Hao, Li-Mei Liu, Yu-Ying Liu, Juan Liu, Li Yan, Chun-Shui Pan, Ming-Xia Wang, Chuan-She Wang, Jing-Yu Fan, Yuan-Sheng Gao, Jing-Yan Han. Inhibitory effect of rhynchophylline on contraction of cerebral arterioles to endothelin 1: Role of rho kinaseJournal of Ethnopharmacology 2014; 155(1): 147 doi: 10.1016/j.jep.2014.04.050
5
Fei Liu, Hua Zhu, Chuangui Li, Xinfeng Lin, Chiyi Xiong, Chun Li, Zhi Yang. Design and radio-synthesis of somatostatin receptors targeted 68Ga-DOTA-Benereotide for non-invasive PET imagingJournal of Radioanalytical and Nuclear Chemistry 2016; 307(2): 1069 doi: 10.1007/s10967-015-4241-z
6
Xiaoqi Zhou, Chenyu Song, Lujie Li, Yangdi Wang, Zhoulei Li, Shi-Ting Feng, Yanji Luo, Zhenpeng Peng. CT-based nomogram development and validation to predict SSTR2, VEGFR2 and MGMT expression for pancreatic neuroendocrine neoplasmsChinese Journal of Academic Radiology 2023; 6(3): 100 doi: 10.1007/s42058-023-00124-x
7
C. Susini, L. Buscail. Rationale for the use of somatostatin analogs as antitumor agentsAnnals of Oncology 2006; 17(12): 1733 doi: 10.1093/annonc/mdl105
8
Federico Gatto, Federica Barbieri, Marica Arvigo, Stefano Thellung, Jessica Amarù, Manuela Albertelli, Diego Ferone, Tullio Florio. Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine NeoplasmsInternational Journal of Molecular Sciences 2019; 20(16): 3940 doi: 10.3390/ijms20163940
9
Reuven Reich, Yiffat Katz, Rivka Hadar, Eli Breuer. Carbamoylphosphonate Matrix Metalloproteinase Inhibitors 3: In vivo Evaluation of Cyclopentylcarbamoylphosphonic Acid in Experimental Metastasis and AngiogenesisClinical Cancer Research 2005; 11(10): 3925 doi: 10.1158/1078-0432.CCR-04-1985
10
Manuel D. Gahete, David Rincón-Fernández, Mario Durán-Prado, Marta Hergueta-Redondo, Alejandro Ibáñez-Costa, Alejandro Rojo-Sebastián, Francisco Gracia-Navarro, Michael D. Culler, Oriol Casanovas, Gema Moreno-Bueno, Raúl M. Luque, Justo P. Castaño. The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patientsOncotarget 2016; 7(37): 60110 doi: 10.18632/oncotarget.11076
11
Nicolas Carrere, Fabienne Vernejoul, Anny Souque, Amani Asnacios, Nicole Vaysse, Lucien Pradayrol, Christiane Susini, Louis Buscail, Pierre Cordelier. Characterization of the Bystander Effect of Somatostatin Receptor sst2 After In Vivo Gene Transfer into Human Pancreatic Cancer CellsHuman Gene Therapy 2005; 0(0): 050921065448001 doi: 10.1089/hum.2005.16.ft-120
12
I. M. MODLIN, M. PAVEL, M. KIDD, B. I. GUSTAFSSON. Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumoursAlimentary Pharmacology & Therapeutics 2010; 31(2): 169 doi: 10.1111/j.1365-2036.2009.04174.x
13
Agnieszka Milewska-Kranc, Jarosław B. Ćwikła, Agnieszka Kolasinska-Ćwikła. The Role of Receptor–Ligand Interaction in Somatostatin Signaling Pathways: Implications for Neuroendocrine TumorsCancers 2023; 16(1): 116 doi: 10.3390/cancers16010116
14
Jonathan Strosberg. Neuroendocrine Tumours2015; : 523 doi: 10.1007/978-3-662-45215-8_30
15
M. Annunziata, R. M. Luque, M. Duran-Prado, A. Baragli, C. Grande, M. Volante, M. D. Gahete, F. Deltetto, M. Camanni, E. Ghigo, J. P. Castano, R. Granata. Somatostatin and somatostatin analogues reduce PDGF-induced endometrial cell proliferation and motilityHuman Reproduction 2012; 27(7): 2117 doi: 10.1093/humrep/des144
16
Panagiotis J. Vlachostergios, Ioannis A. Voutsadakis, Christos N. Papandreou. The shaping of invasive glioma phenotype by the ubiquitin–proteasome systemCell Communication & Adhesion 2013; 20(5): 87 doi: 10.3109/15419061.2013.833192
17
Haliza Haniff, Robert D. Murray. Growth Hormone Related Diseases and Therapy2011; : 271 doi: 10.1007/978-1-60761-317-6_14
18
Nicolas Carrere, Fabienne Vernejoul, Anny Souque, Amani Asnacios, Nicole Vaysse, Lucien Pradayrol, Christiane Susini, Louis Buscail, Pierre Cordelier. Characterization of the Bystander Effect of Somatostatin Receptor sst2 AfterIn VivoGene Transfer into Human Pancreatic Cancer CellsHuman Gene Therapy 2005; 16(10): 1175 doi: 10.1089/hum.2005.16.1175
19
Bernadette V. Marquez, Oluwatayo F. Ikotun, Jesse J. Parry, Buck E. Rogers, Claude F. Meares, Suzanne E. Lapi. Development of a Radiolabeled Irreversible Peptide Ligand for PET Imaging of Vascular Endothelial Growth FactorJournal of Nuclear Medicine 2014; 55(6): 1029 doi: 10.2967/jnumed.113.130898
20
Jonathan R. Strosberg, Asima Cheema, Larry K. Kvols. A Review of Systemic and Liver-Directed Therapies for Metastatic Neuroendocrine Tumors of the Gastroenteropancreatic TractCancer Control 2011; 18(2): 127 doi: 10.1177/107327481101800207
21
Shaoyu Yan, Min Li, Hong Chai, Hui Yang, Peter H. Lin, Qizhi Yao, Changyi Chen. TNF-α decreases expression of somatostatin, somatostatin receptors, and cortistatin in human coronary endothelial cellsJournal of Surgical Research 2005; 123(2): 294 doi: 10.1016/j.jss.2004.07.244
22
Taymeyah Al-Toubah, Jonathan Strosberg. Neuroendocrine Tumours2024; : 619 doi: 10.1007/978-3-031-56968-5_30
23
M. Kilian, J. I. Gregor, I. Heukamp, K. Helmecke, M. Hanel, B. Wassersleben, M. K. Walz, I. Schimke, G. Kristiansen, F. A. Wenger. Impact of Octreotide and SOM-230 on liver metastasis and hepatic lipidperoxidation in ductal pancreatic adenocarcinoma in Syrian HamsterClinical & Experimental Metastasis 2009; 26(7): 719 doi: 10.1007/s10585-009-9271-x